Yeah I’m familiar with Prior Authorisation having owned Clinuvel stock previously. From memory, I think once the initial PR has been approved and the codes used to identify the type and class of drug has been established to facilitate payments from health insurers, the PR process tends to run smoothly as in its a reasonably seamless process. That’s interesting about the 30 day supply fill, totally makes sense given the drug is not cheap.
Daybue Rollout, page-82
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |